Gyrolab® p24 Kit
The Gyrolab® p24 Kit enables rapid quantification of p24 protein for lentivirus titer determinations.
Receive your quote directly from the manufacturer.
The Gyrolab® p24 Kit is made with highly selective antibodies for quantitation of p24 proteins for determination of lentivirus titer. The Gyrolab p24 Kit includes pre-labeled capture and detect reagents, pre-diluted standards, buffers, consumables, and a Gyrolab Bioaffy™ 1000 disc (96 data points). Analytical range approximately 4 logs, or 0.2 ng/mL to 1000 ng/mL (neat concentrations) using Gyrolab Bioaffy 1000 discs.
Increasing productivity in cell and gene therapy bioprocessing with fast and reliable immunoassays
In this white paper, Gyros Protein Technologies discusses the crucial role of immunoassay platforms in ensuring the timely release of safe and effective cell and gene therapeutics. Choosing the right platform involves considering various factors, including robustness, quick data generation from limited samples, support for rapid method development, and flexibility for novel assays. Automation and walk-away systems are essential for reducing manual labor and minimizing errors, allowing personnel to focus on more critical tasks. Additionally, ready validation and software that enables 21 CFR Part 11 compliance are necessary to meet regulatory guidelines.
Accelerating COVID-19 R&D work-flows with microfluidic immunoassays
In this white paper, Gyros Protein Technologies illustrates the contribution of automated flow-through microfluidic immunoassays using Gyrolab system in generating reliable data for applications in public health and the development of vaccines and antibody-based treatments.
One-hour, microfluidic SARS-CoV-2 antibody immunoassay
In this white paper, Gyros Protein Technologies demonstrates how high-quality reagents from Sino Biological can be used in a high-performance, one-hour microfluidic, nanoliterscale immunoassay using Gyrolab® platform for the qualitative detection of total antibodies generated against the receptor binding domain (RBD) of the spike protein of SARS-CoV-2 in human serum samples.
Download it below to explore details of the miniaturized, microfluidic SARS-CoV-2 antibody immunoassay development and learn more about the future directions for Gyrolab assay development to detect SARS-CoV-2 antibodies.
Automated approaches to improving immunoassays - SelectScience and Gyros Protein Technologies Podcast
At the Bioprocessing Summit in Boston, SelectScience® spoke with Todd Glynn from Gyros Protein Technologies for this special Podcast.
We spoke about the Gyrolab® immunoassay kits and solutions for cell and gene therapy viral vector titer and impurity analysis, and how they benefit their customers.
Automated approaches to improving immunoassays
Find out how the immunoassay kits from Gyros Protein Technologies can support your cell and gene therapy viral vector titer and impurity analyses
